NCT00592332View on ClinicalTrials.gov

Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2009

Conditions
Type 1 Diabetes
Interventions
DRUG

Alprazolam

1 mg alprazolam given orally 60 minutes prior to each 2 hour glucose clamp on day 1 (x2)

OTHER

control group

control group is two hyperinsulinemic glucose clamps on day 1 with no drug given.

Trial Locations (1)

37232

Vanderbilt University, Nashville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Vanderbilt University

OTHER

NCT00592332 - Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2 | Biotech Hunter | Biotech Hunter